Our syndicated research services supply global market intelligence across a broad range of disease areas, quickly and cost-effectively
We are committed to providing accurate, ongoing market information using innovative, up-to-the-minute market research techniques to the pharma industry.
Therapy Watch: our real-time patient tracking tool provides instant access to the very latest market data including market shares, switch patterns, treatment patterns and patient demographics.
Living With: our series of patient reports offering in-depth insight into the patient journey from pre-diagnosis to stabilisation. These reports are based on quantitative market research studies conducted amongst large samples of patients living with specific chronic illnesses.
Sharing our knowledge
We offer complimentary workshops on the patient journey referencing our Living With and Therapy Watch data. Workshops are held in your offices at a date and time to suit you and the agenda can be tailored to meet your requirements.
We run a series of webinars referencing findings from our syndicated research.
Visit Rapport to download a recording of past webinars and find out about forthcoming events.
- Some example case studiesPatient Assistance Programme Evaluation for Cardiovascular Conditions
The challengeOur client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product. The client wanted to understand how successful the PAP was at meeting the needs of patients, trainers and prescribers, and whether it positively differentiated them from competitors. They wanted to evaluate each individual component…read more »Multiple Sclerosis new medical device research
The challengeOur client wanted to find out how best to develop an implantable delivery device with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a device would be accepted by HCPs and patients. We also needed to identify the perceived benefit to stakeholders and offer ideas on how to optimize the device offering through the look of the…read more »Shifting perceptions of the use of probiotics in IBS Management
The challengeOur client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range of healthcare professionals in emerging markets. They wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to…read more »
- Our latest webinarsWebcast: Exploring the opportunity for women’s health in emerging markets
With women accounting for half of the global population, women’s healthcare is an important market for the pharmaceutical industry. When thinking about women’s health, we tend to think about diseases which are linked specifically to female biology. However, it is important to not over-simplify this definition; women’s healthcare also includes diseases which are more prevalent in women and health purchasing behaviour which is more common among females (e.g. aesthetic treatment), all…read more »Live from Singapore: Understanding patient willingness to pay in emerging markets
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets? A key feature of emerging markets is that patients often have to self-fund a high proportion of their healthcare costs. While private health insurance coverage is increasing in many emerging markets, penetration typically remains low, even among middle to high income segments of the population.…read more »